Sun February 9, 2014
Medications for Multiple Sclerosis Aimed at Preventing Worsening of Disease
Originally published on Fri September 12, 2014 2:03 pm
Neurologists, who treat patients with Multiple Sclerosis, are excited to have many more FDA approved Multiple Sclerosis therapies on the market. Several more are in clinical trials or awaiting approval. Dr. April Erwin, a neurologist with Neuromedical Center in Baton Rouge, is optimistic that a cure is on the horizon. For more information about Multiple Sclerosis and treatment, please visit www.theneuromedicalcenter.com.
Notes from New Orleans